Trial NCT03637803

View at ClinicalTrials.gov 
Org. Study IDs: MRx0518-I-002
Secondary IDs: Keynote MK3475-823

Last trial update was posted on 2023-06-01

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Renal Cell

Other Conditions

Bladder Cancer Melanoma Non Small Cell Lung Cancer Oncology Renal Cell Carcinoma Solid Tumor

Stopping Reasons

Sponsor insolvency

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID